BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28666474)

  • 1. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
    Su T; Jin Q; Liu Z
    BMC Nephrol; 2017 Jun; 18(1):208. PubMed ID: 28666474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the surface-treated AN69 membrane prolong filter survival in CRRT without anticoagulation?
    Schetz M; Van Cromphaut S; Dubois J; Van den Berghe G
    Intensive Care Med; 2012 Nov; 38(11):1818-25. PubMed ID: 22773036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of AN69 ST membrane on filter lifetime in continuous renal replacement therapy without anticoagulation in patients with high risk of bleeding].
    Yin Y; Zhao C; Hu Z; Wei S; Huo Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):343-8. PubMed ID: 26003637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).
    Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y
    Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
    Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
    Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of ionic interactions in cytokine adsorption of polyethyleneimine-coated polyacrylonitrile and polymethyl methacrylate membranes in vitro.
    Moriyama K; Kato Y; Hasegawa D; Kurimoto Y; Kawaji T; Nakamura T; Kuriyama N; Shimomura Y; Nishida O
    J Artif Organs; 2020 Sep; 23(3):240-246. PubMed ID: 32394409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial.
    Nakamura Y; Hatomoto H; Yamasaki S; Yamauchi K; Kiyomi F; Hoshino K; Kawano Y; Nakano T; Hasegawa T; Ishikura H
    Eur J Med Res; 2023 Jun; 28(1):208. PubMed ID: 37391846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
    Tang IY; Cox DS; Patel K; Reddy BV; Nahlik L; Trevino S; Murray PT
    Ann Pharmacother; 2005 Feb; 39(2):231-6. PubMed ID: 15632219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z; Ni H; Lu B
    ASAIO J; 2012; 58(1):46-50. PubMed ID: 22210650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
    Kozek-Langenecker SA; Kettner SC; Oismueller C; Gonano C; Speiser W; Zimpfer M
    Crit Care Med; 1998 Jul; 26(7):1208-12. PubMed ID: 9671370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Polyethylenimine-Coated AN69ST Membrane in Continuous Renal Replacement Therapy with the Intensive Care Outcomes: Observations from a Claims Database from Japan.
    Doi K; Iwagami M; Yoshida E; Marshall MR
    Blood Purif; 2017; 44(3):184-192. PubMed ID: 28609776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial.
    Fealy N; Aitken L; du Toit E; Lo S; Baldwin I
    Crit Care Med; 2017 Oct; 45(10):e1018-e1025. PubMed ID: 28658026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
    François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
    BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.